Français
ItalianoBond Bristol Myers Squibb 4.5% ( US110122AX68 ) in USD
| Issuer | Bristol Myers Squibb | ||||||
| Market price |  85.97 % ▲ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US110122AX68 ( in USD )
|
||||||
| Interest rate | 4.5% per year ( payment 2 times a year) | ||||||
| Maturity | 01/03/2044 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 500 000 000 USD | ||||||
| Cusip | 110122AX6 | ||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||
| Next Coupon | 01/09/2026 ( In 5 days ) | ||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb issued a US$500,000,000 4.5% bond (CUSIP: 110122AX6, ISIN: US110122AX68) maturing on March 1, 2044, with a minimum purchase amount of $2,000, currently trading at 100% of par value, paying semi-annually, and rated A+ by S&P and A2 by Moody's. |
||||||
| |||||||